LCB01-0699

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLCB01-0699
Drug Alias NameLCB01-0699
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial proteins synthesis inhibitors
TargetsBacterial proteins
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesLigaChem Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChangzhou Longsai Medical Technology Co LtdLigaChem Biosciences Inc
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A